Navigation Links
Kingfisher Healthcare Launches Breakthrough Product in Europe
Date:9/19/2007

LEUVEN, Belgium, September 19 /PRNewswire/ -- Kingfisher Healthcare (KFH) announces the launch of KFH Energy, a product to alleviate fatigue and pain, two common problems associated with chronic diseases such as post polio syndrome, fibromyalgia and multiple sclerosis. KFH Energy is a patented, high-tech medical device for home use.

The KFH Energy utilizes Bio-Electric Stimulation Therapy (BEST) to deliver extremely low currents to the body. BEST works by enhancing the physiological processes at cellular level, documented effects include:

- an increase in ATP production, the molecule that delivers energy to all cells in the body

- increased synthesis of proteins, the building blocks of the body

The founder and CEO of KFH, Dr Henk Snyman, said: "We are very proud to introduce such a superior and safe solution to the many people suffering from fatigue, pain and lack of stamina. We are dedicated to continuing research and are exploring further applications in ongoing clinical trials."

The 1st clinical trial showed excellent results in post polio patients, and KFH has decided to support further research into the puzzling deterioration that many polio patients experience later in life. Dr Snyman indicated: "We are therefore very pleased to announce the creation of an annual Marianne Liefers Post polio Research Award, to the value of CAD$5.000. An independent panel will decide each year which project to support, and it is also recognition of the tireless and dedicated way in which Mrs Liefers - one of the first patient to be treated - has helped us to discover the positive effects that KFH Energy can have in the lives of people who had polio as children.

Note to Editors:

KFH is a young healthcare company , developing its own pipeline of proprietary products. It utilizes a technology platform called BEST (Bio-Electric Stimulation Therapy), from which unique products are developed. These products alleviate specific symptoms associated with chronic conditions, including chronic fatigue in post polio syndrome, fibromyalgia, multiple sclerosis and others, and the healing of chronic wounds such as leg ulcers, decubitus ulcers, and others. For more information, including vodcast testimonials from patients, see http://www.kfhealth.com.


'/>"/>
SOURCE Kingfisher Healthcare
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Web-based reporting credited with states top healthcare ranking
2. Visions: Preizler offers insurers perspective on healthcare IT
3. Federal bill would set healthcare IT standards
4. IRS ruling could speed healthcare technology adoption
5. Bill would provide federal aid for healthcare IT
6. DHC 2007: Hayden says technology creates magic moment for healthcare delivery
7. Digital Healthcare Conference 2007: Mounting obstacles for health IT
8. Georgia healthcare system to install GEs radio frequency ID
9. GE Healthcare leads compact ultrasound market
10. CIO Leadership Series: Greg Smith, Wheaton Franciscan Healthcare
11. Merge Healthcare suffers $258M loss in `06
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/25/2017)... ... February 25, 2017 , ... The ... in an ongoing effort to create meaningful change by increasing communication, partnerships and ... emphasis on consumers and patients’ mental health well-being. , Both organizations are dedicated ...
(Date:2/24/2017)... DIEGO , Feb. 24, 2017  Aethlon Medical, ... following note authored by its Chairman and CEO, ... at the Munich Security Conference last Saturday, Bill ... virus could kill more people than nuclear weapons. Mr. ... U.S. and U.K. intelligence agencies, that scientific terrorists have ...
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" ... in China, today announced its financial results for the fourth ... Quarter 2016 Financial Highlights Total sales ... RMB terms, or increased by 13.6% in USD terms to ... 2015. Gross profit increased by 13.3% to ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook ... portfolio to include an array of biochemical analyses critical for Lead Discovery. ... their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of action, ...
Breaking Biology Technology:
(Date:1/31/2017)... Mass. , Jan. 31, 2017  Spero ... novel therapies for the treatment of bacterial infections, ... set of antibacterial candidates from Pro Bono Bio ... increased prevalence of multi-drug resistant forms of Gram-negative ... Cantab Anti Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)... 26, 2017  Acuity Market Intelligence today released ... Digital Identity".  Acuity characterizes 2017 as a "breakout" ... adoption reflects a new understanding of the potential ... and digital identity are often perceived as threats ... , Principal of Acuity Market intelligence. "However, taken ...
(Date:1/24/2017)... 24, 2017  It sounds simple and harmless—an ... monitors vital signs and alerts parents on their ... saturation level drops. But pediatric experts argue that ... with no evidence of medical benefits, especially to ... aggressively to parents of healthy babies, promising peace ...
Breaking Biology News(10 mins):